Roivant Sciences Ltd.
Roivant Sciences Ltd.（ROIV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
roiv · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$42.00
Consensus
$37.17
+29.4% upside
Low
$30.00
Median: $38 · Last Close: $28.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$37.17
29.4% upside
High Target
$42
46.3%
Low Target
$30
4.5%
Current Price
$28.71
as of today
Based on analyst price targets, the ROIV stock price prediction for the next 12 months ranges from $30 to $42. The consensus ROIV price forecast of $37.17 implies 29.4% upside from the current price of $28.71.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.26 | ↓ 1.59% |
1-day model range: $28.08–$28.44. Peak: $28.44 (-1.59%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $36 | +27.0% |
| 2028 | $43 | +49.4% |
| 2029 | $48 | +66.4% |
| 2030 | $51 | +78.8% |
| 2031 | — | +87.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ROIV · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-21 | Citigroup | Maintains | Buy→Buy |
| 2026-05-21 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-16 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-10 | Citigroup | Maintains | Buy→Buy |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | Guggenheim | Maintains | Buy→Buy |
| 2025-12-15 | Leerink Partners | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Roivant Sciences Ltd. (ROIV) stock. Of the recent 79 rating actions, 0 were upgrades and 0 were downgrades. 15 analysts currently cover ROIV.
分析师推荐趋势
ROIV analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$82M
↓ 95.5% YoY
Revenue Next Year
$605M
↑ 635.1% YoY
EPS This Year
$-1.25
EPS Next Year
$-0.98
↓ 21.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ROIV EPS of $-1.25 for the current fiscal year, based on estimates from 4 analysts. The ROIV revenue forecast is $82M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ROIV 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ROIV 的共识目标价为 $37.17（+29.4% 上行空间），分析师共识为 Buy。
ROIV 的短期预测（明日）为 $28.26（-1.59%）。 ROIV 对 2027 年的股价预测均值为 $36。 ROIV 对 2030 年的预测区间为 $48–$55。
Roivant Sciences Ltd. 在 NASDAQ 上市，代码 ROIV。ROIV 在 2027 年的整体展望偏积极，在覆盖分析师中约 93% 对应 Buy 共识。
常见问题
ROIV 预测 · 8 个问题根据 15 位华尔街分析师，ROIV 的 12 个月平均目标价为 $37.17，最高 $42.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $28.71，隐含约 +29.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.